Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.70, marking a -3.29% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.

Blockchain networks face a quiet but serious problem that grows over time. As transactions pile up, nodes must store more ...

The HASH vs ICHI lawsuit presents claims for crypto fraud and theft for U.S. courts.According to the lawsuit, highly ...

Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...

I would never have proposed this exhibition in her lifetime. This is, after all, a writer who said in an interview, “Don’t ...

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

Former Speaker of the House Nancy Pelosi (D-Calif.) remains one of the most-followed members of Congress when it comes to ...

The market is rapidly transitioning from episodic diagnostics to continuous health monitoring. By 2035, the integration of ...

The site, which will cost about €10.0 billion ($11.7 billion) to complete, will be the third-largest of the company’s Verbund ...

CloseMate is the only platform built entirely around the concept of Service as Software. Where traditional SaaS sells access ...